Cardiometabolic Risk in Hyperlipidemic Men and Women

Table 2

Characteristics of the study sample with prediabetes, divided by sex.

	(female/male)	Female	Male	value
Age [years]	19/29			0.007
Body weight	19/28			<0.001
BMI [kg/m^2]	19/28			0.360
Waist [cm]	18/27			0.001
RRS [mmHg]	14/20			0.164
RRD [mmHg]	14/20			0.223
TC [mg/dL]	19/29			0.371
LDL-C [mg/dL]	18/27			0.746
HDL-C [mg/dL]	17/27			<0.001
NHDL-C [mg/dL]	17/27			0.640
ln(TG) [mg/dL]	19/29			0.165
ln(TG/HDL)	17/27			0.003
ln(Lip.a) [units]	17/26			0.013
IMT-left [mm]	17/26			0.576
IMT-right [mm]	17/26			0.463
IMT av [mm]	17/26			0.834
Glucose [mg/dL]	19/27			0.882
ln(insulin+1) [μU/mL]	17/27			0.273
C-peptide [ng/mL]	16/23			0.656
HbA1c [%]	19/28			0.322
QUICKI-test	16/23			0.478
ln(proBNP) [units]	16/23			0.905
ln(hsCRP+1) [units]	17/28			0.440
ln(GOT) [mg/dL]	18/29			0.499
ln(GPT) [mg/dL]	18/29			0.098
ln(GGT) [mg/dL]	18/29			0.048
Ezetimibe	19/23	2 (10.5)	3 (13.0)	1.000
Nicotinic acid	19/23	0 (0.0)	2 (8.7)	0.556
Fibrates	19/23	2 (10.5)	9 (39.1)	0.081
Statins	19/23	11 (57.9)	19 (82.6)	0.155
CVD	18/27	1 (5.6)	8 (29.6)	0.110
Mean steps 7 days	17/21			0.114
Metabolic syndrome	12/20	5 (41.7)	12 (60.0)	0.522
Mean treatment duration of the last taken dyslipidemic medication (days)	18/28			0.938

-test, Chi-square test.
Data are presented as number of observations () and means ± standard deviation. BMI (body mass index), waist (waist circumference), RRS (systolic blood pressure), RRD (diastolic blood pressure), TC (total cholesterol), LDL-C (low density lipoprotein cholesterol), HDL-C (high density lipoprotein cholesterol), NHDL-C (non-high density lipoprotein cholesterol), TG (triglycerides), TG/HDL (triglyceride/HDL-cholesterol ratio), Lip.a (lipoprotein (a)), IMT (carotid intima media thickness), HbA1c (glycated hemoglobin A1c), QUICKI (quantitative insulin sensitivity check index), proBNP (pro B-type natriuretic peptide), hsCRP (high sensitive C-reactive protein), GOT (glutamate-oxaloacetate transaminase), GPT (glutamate-pyruvate transaminase), GGT (gamma-glutamyl transferase), and CVD (cardiovascular disease).